Dapagliflozin, a novel, selective SGLT2 inhibitor, improved glycemic control over 2 weeks in patients with type 2 diabetes mellitus (Q46171591)
Jump to navigation
Jump to search
scientific article published on 7 January 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Dapagliflozin, a novel, selective SGLT2 inhibitor, improved glycemic control over 2 weeks in patients with type 2 diabetes mellitus |
scientific article published on 7 January 2009 |
Statements
1 reference
Dapagliflozin, a novel, selective SGLT2 inhibitor, improved glycemic control over 2 weeks in patients with type 2 diabetes mellitus (English)
1 reference
B Komoroski
1 reference
N Vachharajani
1 reference
Y Feng
1 reference
L Li
1 reference
D Kornhauser
1 reference
M Pfister
1 reference
7 January 2009
1 reference
85
1 reference
513-519
1 reference
5
1 reference
Identifiers
1 reference
1 reference